Evidence map›Paper›PMID 28059114›Full record

ArticleScientific reports2017

Cigarette smoke extract profoundly suppresses TNFα-mediated proinflammatory gene expression through upregulation of ATF3 in human coronary artery endothelial cells.

Jack E Teasdale, Georgina G J Hazell, Alasdair M G Peachey, Graciela B Sala-Newby, Charles C T Hindmarch, Tristan R McKay, Mark Bond, Andrew C Newby, Stephen J White

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Pathogenesis of plaque erosion.Trends in cardiovascular medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.American journal of physiology. Lung cellular and molecular physiology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. ATF3 in atherosclerosis: a controversial transcription factor.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  13. Epigenetic Regulation ofCirculation research · 2022
    Article
  14. Toll-Like Receptors/TNF-BioMed research international · 2022
    Article
  15. Article
  16. Article
  17. IL-36 Cytokines Promote Inflammation in the Lungs of Long-Term Smokers.American journal of respiratory cell and molecular biology · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jack E TeasdaleSchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Georgina G J HazellSchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Alasdair M G PeacheySchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Graciela B Sala-NewbySchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Charles C T HindmarchDepartment of Biomedical and Molecular Sciences, Queen's University, Kingston, ON, Canada, K7L 3N6.
Tristan R McKaySchool of Healthcare Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK.
Mark BondSchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Andrew C NewbySchool of Clinical Sciences, University of Bristol, Bristol Royal Infirmary, Bristol, BS2 8HW, UK.
Stephen J WhiteSchool of Healthcare Sciences, Manchester Metropolitan University, Manchester M1 5GD, UK.
University of Bristol · GBManchester Metropolitan University · GBQueen's University · CA

Funding

British Heart Foundation FS/12/77/29887British Heart Foundation FS/16/9/32012British Heart Foundation PG/11/44/28972British Heart Foundation RG/09/006/27918National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/L001780/1
6 · The paper itself

Abstract

Endothelial dysfunction caused by the combined action of disturbed flow, inflammatory mediators and oxidants derived from cigarette smoke is known to promote coronary atherosclerosis and increase the likelihood of myocardial infarctions and strokes. Conversely, laminar flow protects against endothelial dysfunction, at least in the initial phases of atherogenesis. We studied the effects of TNFα and cigarette smoke extract on human coronary artery endothelial cells under oscillatory, normal laminar and elevated laminar shear stress for a period of 72 hours. We found, firstly, that laminar flow fails to overcome the inflammatory effects of TNFα under these conditions but that cigarette smoke induces an anti-oxidant response that appears to reduce endothelial inflammation. Elevated laminar flow, TNFα and cigarette smoke extract synergise to induce expression of the transcriptional regulator activating transcription factor 3 (ATF3), which we show by adenovirus driven overexpression, decreases inflammatory gene expression independently of activation of nuclear factor-κB. Our results illustrate the importance of studying endothelial dysfunction in vitro over prolonged periods. They also identify ATF3 as an important protective factor against endothelial dysfunction. Modulation of ATF3 expression may represent a novel approach to modulate proinflammatory gene expression and open new therapeutic avenues to treat proinflammatory diseases.

Indexed as

Up-RegulationActivating Transcription Factor 3AntioxidantsCells, CulturedCoronary VesselsCytokinesEndothelial CellsGene Expression ProfilingGene Expression RegulationHumansModels, BiologicalNicotianaShear StrengthSmokeStress, MechanicalTumor Necrosis Factor-alphaActivating Transcription Factor 3AntioxidantsATF3 protein, humanCytokinesSmokeTumor Necrosis Factor-alpha

Identifiers

PMID28059114
PMCPMC5216376
OpenAlexW2569125373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.